In Tajikistan, an estimated 7800 people fell ill with active TB in 2022. In terms of multidrug-resistant TB (MDR-TB), Tajikistan belongs to the 27 countries with the highest burden (globally).

To optimise the use of the available funds and other resources, UNDP, the Global Fund Principal Recipient…

The Health Systems Support Unit has built an economic model for use at country-level to estimate the value-added for changing treatment to the BPaL/BPaLM regimens for appropriate drug resistant TB patient groups. The Global Alliance for TB Drug Development (TB Alliance) has commissioned this work so…

Two studies will be performed in Switzerland: the first study will establish the patient delay (time from the onset of symptoms suggesting tuberculosis (TB) to the time the patient approached a health-care provider) and the health system delay (time from the first contact to a health-care provider…